Acyl-CoA synthetase long chain 4 (ACSL4), one of the ACSL family member that is crucial for fatty acid activation[4], is dysregulated in HCC and associated with poor outcomes of HCC patients [4, 5]. Here, ACSL4 is linked to hepatocellular carcinoma.